» Articles » PMID: 11857563

Familial Paraganglioma and Gastric Stromal Sarcoma: a New Syndrome Distinct from the Carney Triad

Overview
Journal Am J Med Genet
Specialty Genetics
Date 2002 Feb 22
PMID 11857563
Citations 90
Authors
Affiliations
Soon will be listed here.
Abstract

Paragangliomas may be inherited in an autosomal dominant manner either alone (as in PGL1, PGL2, and PGL3 syndromes) or as a component of a multiple tumor syndrome (as in von Hippel-Lindau disease and neurofibromatosis type 1). In this article, we describe 12 patients (7 male and 5 female) with an average age of 23 years from five unrelated families that manifested paraganglioma and gastric stromal sarcoma; the tumors were inherited in an apparent autosomal dominant manner, with incomplete penetrance. Seven patients had paraganglioma, four had paraganglioma and gastric stromal sarcoma, and one had gastric stromal sarcoma. The paraganglioma was multicentric and the gastric stromal sarcoma multifocal. Because of the rarity of gastric stromal sarcoma and its multifocality, the young age of the patients, and the unlikelihood of coincidental co-occurrence of paragangliomas and gastric stromal sarcomas, we suggest that a new syndrome exists with these two main components, a condition that is familial and distinct from the Carney triad.

Citing Articles

Gastrointestinal Stromal Tumors (GISTs) in Pediatric Patients: A Case Report and Literature Review.

Popoiu T, Pirvu C, Popoiu C, Iacob E, Talpai T, Voinea A Children (Basel). 2024; 11(9).

PMID: 39334573 PMC: 11429550. DOI: 10.3390/children11091040.


Case report: detection of multiple sporadic gastrointestinal stromal tumors by dual-time F-FDG PET/CT.

Li C, Li W, Shang M, Wang P, Hu X Front Oncol. 2024; 14:1321179.

PMID: 38606109 PMC: 11007083. DOI: 10.3389/fonc.2024.1321179.


An aggressive cabergoline-resistant, temozolomide-responsive macroprolactinoma due to a germline pathogenic variant in the absence of paraganglioma or pheochromocytoma.

Alzahrani A, Bin Nafisah A, Alswailem M, Moria Y, Poprawski D, Al-Hindi H Front Endocrinol (Lausanne). 2023; 14:1273093.

PMID: 38152133 PMC: 10751293. DOI: 10.3389/fendo.2023.1273093.


Germline Mutations in SDH-Deficient GISTs: A Current Update.

Schipani A, Nannini M, Astolfi A, Pantaleo M Genes (Basel). 2023; 14(3).

PMID: 36980917 PMC: 10048394. DOI: 10.3390/genes14030646.


Expanded genetic testing of GIST patients identifies high proportion of non-syndromic patients with germline alterations.

Mandelker D, Marra A, Mehta N, Selenica P, Yelskaya Z, Yang C NPJ Precis Oncol. 2023; 7(1):1.

PMID: 36593350 PMC: 9807588. DOI: 10.1038/s41698-022-00342-z.